AlzeCure gets presentation accepted on disease-modifying effects of ACD856 at Alzheimer's conference

AlzeCure gets presentation accepted on disease-modifying effects of ACD856 at Alzheimer’s conferenceAlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alz...

Related Keywords

Sweden ,Swedish ,Johan Sandin ,Azita Rasti ,Gunnar Nordvall ,Veronica Lidell ,Pontus Forsell ,Head Of Discovery Research At Alzecure Pharma ,Clinical Trials ,Alzecure Pharma ,Nasdaq First North Premier Growth Market ,Nerve Growth Factor ,Brain Derived Neurotrophic Factor ,